Alemtuzumab
Showing 401 - 419 of 419
Leukemia Trial in United States (biological, drug, procedure, radiation)
Completed
- Leukemia
- alemtuzumab
- +4 more
-
Chicago, Illinois
- +13 more
Jan 26, 2010
End-Stage Renal Disease, Living Donors Trial in Miami (Anti-Thymocyte Globulin vs Campath-1H vs Daclizumab)
Completed
- End-Stage Renal Disease
- Living Donors
- Anti-Thymocyte Globulin vs Campath-1H vs Daclizumab
-
Miami, FloridaUniversity of Miami Jackson Memorial Hospital
Jan 11, 2010
Investigate Reparative and Regenerative Potential of Alemtuzumab
Completed
- Multiple Sclerosis
- (no location specified)
Nov 24, 2009
Type 1 Diabetes Trial in Edmonton (alemtuzumab, islet transplant, infliximab)
Completed
- Type 1 Diabetes
- alemtuzumab
- +2 more
-
Edmonton, Alberta, CanadaUniversity of Alberta - Clinical Islet Transplant Program
Oct 1, 2009
Autoimmune Cytopenias Trial in Bangkok (Alemtuzumab)
Terminated
- Autoimmune Cytopenias
- Alemtuzumab
-
Bangkok, ThailandPhramongkutklao Hospital
Jun 18, 2009
Peripheral T-Cell Lymphoma Trial in Bangkoknoi (Alemtuzumab)
Terminated
- Peripheral T-Cell Lymphoma
- Alemtuzumab
-
Bangkoknoi, Bangkok, ThailandSiriraj Hospital, Mahidol University
Jun 24, 2009
Severe Combined Immunodeficiency Trial in Memphis (procedure, drug, device)
Completed
- Severe Combined Immunodeficiency
- Stem cell transplant
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 19, 2009
Campath and Rebif Treatment on Cognition in Multiple Sclerosis
Unknown status
- Relapsing Remitting Multiple Sclerosis
-
Berkely, California
- +6 more
Jun 4, 2009
B-Cell Chronic Lymphocytic Leukemia Trial in La Jolla, Boston, Houston (Alemtuzumab (Campath-1H))
Unknown status
- B-Cell Chronic Lymphocytic Leukemia
- Alemtuzumab (Campath-1H)
-
La Jolla, California
- +2 more
Dec 2, 2008
T-Cell Lymphoma, Lymphoma, Non-Hodgkin's Trial in New York (CHOP and alemtuzumab)
Completed
- T-Cell Lymphoma
- Lymphoma, Non-Hodgkin's
- CHOP and alemtuzumab
-
New York, New YorkWeill Medical College of Cornell University
Oct 21, 2008
Adult Acute Lymphocytic Leukemia T-Cell, Lymphoma, Lymphoblastic Trial in Frankfurt (Alemtuzumab (MabCampath), Cladribine)
Completed
- Adult Acute Lymphocytic Leukemia T-Cell
- Lymphoma, Lymphoblastic
- Alemtuzumab (MabCampath)
- Cladribine
-
Frankfurt, GermanyUniversity Hospital, Medical Dept. II
May 29, 2008
Living-Donor Kidney Transplant Trial in Miami (Thymoglobulin, Campath-1H, Daclizumab)
Completed
- Living-Donor Kidney Transplant
- Thymoglobulin
- +2 more
-
Miami, FloridaUniversity of Miami Division of Transplantation
May 23, 2008
Renal Transplantation Trial in Miami (Thymoglobulin, Campath-1H, Daclizumab)
Completed
- Renal Transplantation
- Thymoglobulin
- +2 more
-
Miami, FloridaUniversity of Miami Division of Transplantation
May 27, 2008
Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute Trial in Tehran (Haploidentical hematopoietic stem cell
Completed
- Leukemia, Myeloid, Acute
- Leukemia, Lymphoblastic, Acute
- Haploidentical hematopoietic stem cell transplantation
- +5 more
-
Tehran, Iran, Islamic Republic ofHematology-Oncology & BMT Research Center
Nov 15, 2008
Chronic Lymphocytic Leukemia Trial in Houston (ISF35)
Completed
- Chronic Lymphocytic Leukemia
- ISF35
-
Houston, TexasUniversity of Texas M.D. Anderson Cancer Center
Oct 23, 2008
B-CLL Trial in Stockholm (alemtuzumab)
Completed
- B-CLL
- alemtuzumab
-
Stockholm, SwedenDept. of Hematology, Karolinska University Hospital
Jul 23, 2007
Mycosis Fungoides, Sezary Syndrome Trial in Lima (alemtuzumab)
Unknown status
- Mycosis Fungoides
- Sezary Syndrome
- alemtuzumab
-
Lima, PeruSchering Peruana S.A.
Apr 2, 2007
B-Cell Chronic Lymphocytic Leukemia Trial (Alemtuzumab)
Unknown status
- B-Cell Chronic Lymphocytic Leukemia
- Alemtuzumab
- (no location specified)
Jul 21, 2006
Kidney Transplant Trial in Bergamo (Campath-1H)
Completed
- Kidney Transplant
-
Bergamo, ItalyHospital "Ospedali Riuniti" of Bergamo
May 18, 2006